skip to content
Systematic Reviews of Treatments for Cancer of the Uterus
Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of treatments for uterine and endometrial cancers.
Reviewed December 2011
10 Resources Found
Results 1 to 10 displayed.
| Title: | Adjuvant chemotherapy for endometrial cancer after hysterectomy |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Womb (uterine/endometrial) cancer is a fairly common disease affecting approximately 1 in 70 women. A hysterectomy is usually curative because most cancers have a low risk of spreading (metastasising) to other sites which may result in a later recurrenc... |
| Date: | Aug 2011 |
| Title: | Adjuvant progestagens for endometrial cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Endometrial (womb) cancer is the most common genital tract cancer in developed countries. Progestagen (a hormone) therapy is sometimes used following initial surgery to reduce the risk of recurrence. However, progestagens have been found to reduce one o... |
| Date: | May 2011 |
| Title: | Hormonal therapy in advanced or recurrent endometrial cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Endometrial cancer is cancer arising from the lining of the womb. Most women with endometrial cancer are diagnosed when their tumour is still confined to the body of the womb. However, about 10% of women with endometrial cancer are diagnosed when the di... |
| Date: | Nov 2010 |
| Title: | Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Carcinosarcomas of the uterus (womb) are uncommon cancers accounting for 4% of all cancers of the womb.These uncommon cancers have poor prognosis, one of the reasons for the poor survival outcome is the fact that over a third of these cancers (carcinosa... |
| Date: | Nov 2010 |
| Title: | High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Improved survival and local control rate have made the combination of external beam radiotherapy (EBRT) and intracavitary brachytherapy (ICBT) the standard treatment for locally advanced uterine cervix cancer. The use of high dose rate (HDR) brachythera... |
| Date: | Jun 2010 |
| Title: | Lymphadenectomy for the management of endometrial cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Cancer arising from the lining of the womb, known as endometrial carcinoma, is now the most common gynaecological cancer in western Europe and North America. Most women (75%) still have their tumour confined to the body of the womb at diagnosis and thre... |
| Date: | Jun 2009 |
| Title: | Hormone therapy in postmenopausal women and risk of endometrial hyperplasia |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Hormone therapy may be used to manage troublesome menopausal symptoms, but is currently recommended to be given at the lowest effective dose and regularly reviewed by a woman and her doctor. In women with an intact uterus hormone therapy comprising estr... |
| Title: | Adjuvant radiotherapy for stage I endometrial cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Women with stage I endometrial cancer have a low risk of recurrence of their disease. About 10% of women treated with surgery alone have a recurrence. This risk is significantly higher (and maybe double) for some women with high risk factors including g... |
| Date: | Feb 2007 |
| Title: | Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | These women have a poor prognosis. Giving extra drugs seems to reduce disease progression by a small amount. However, it does not seem to allow women to live longer. Also, more chemotherapy seems to cause a greater amount of serious short-term side effe... |
| Date: | Jun 2005 |
| Title: | Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Smooth muscle tumours of the uterus (uterine fibroids)are usually asymptomatic, however up to 50% cause symptoms severe enough to warrant therapy, and surgery is the standard treatment. Fibroid growth is stimulated by the hormone oestrogen and gonadotro... |
Results 1 to 10 displayed.
